Holen Sie sich die Stockscreener-App
108.35
0.59%
-0.64
Handel nachbörslich:
107.52
-0.83
-0.77%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KMB?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$108.99
Offen:
$110.26
24-Stunden-Volumen:
3.44M
Relative Volume:
0.75
Marktkapitalisierung:
$35.97B
Einnahmen:
$16.56B
Nettoeinkommen (Verlust:
$1.75B
KGV:
17.04
EPS:
6.36
Netto-Cashflow:
$1.84B
1W Leistung:
-3.61%
1M Leistung:
+6.78%
6M Leistung:
+9.09%
1J Leistung:
-15.29%
1-Tages-Spanne:
$107.74
$111.18
1-Wochen-Bereich:
$105.98
$114.91
52-Wochen-Spanne:
$92.42
$137.46
Kimberly Clark Corp Stock (KMB) Company Profile
Firmenname
Kimberly Clark Corp
Sektor
Telefon
(972) 281-1200
Adresse
351 PHELPS DRIVE, IRVING, TX
Compare KMB vs PG, UL, CL, KVUE, CCL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMB
Kimberly Clark Corp
|
108.35 | 36.18B | 16.56B | 1.75B | 1.84B | 6.36 |
PG
Procter Gamble Co
|
149.98 | 352.78B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
62.39 | 135.03B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
92.98 | 75.27B | 20.80B | 2.22B | 3.77B | 2.5772 |
KVUE
Kenvue Inc
|
18.98 | 36.52B | 15.29B | 1.62B | 1.82B | 0.8433 |
CCL
Colgate Palmolive Co
|
26.41 | 36.79B | 26.98B | 3.10B | 2.98B | 2.2492 |
Kimberly Clark Corp Stock (KMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-13 | Hochstufung | Argus | Hold → Buy |
| 2025-11-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-08-04 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2025-07-18 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-08 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-07-23 | Eingeleitet | TD Cowen | Buy |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2024-06-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-06-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-03-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-03-01 | Fortgesetzt | Goldman | Buy |
| 2023-12-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-11-17 | Eingeleitet | Piper Sandler | Overweight |
| 2023-10-12 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-09-22 | Eingeleitet | HSBC Securities | Hold |
| 2023-03-20 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2023-02-17 | Eingeleitet | Citigroup | Sell |
| 2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2022-12-06 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2022-10-18 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-12 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2022-09-14 | Fortgesetzt | BofA Securities | Neutral |
| 2022-02-02 | Herabstufung | Bernstein | Mkt Perform → Underperform |
| 2022-01-27 | Bestätigt | Citigroup | Sell |
| 2022-01-27 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-01-27 | Bestätigt | UBS | Neutral |
| 2022-01-27 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-11 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-10-26 | Herabstufung | Berenberg | Buy → Hold |
| 2021-09-09 | Eingeleitet | HSBC Securities | Hold |
| 2021-06-24 | Eingeleitet | UBS | Neutral |
| 2021-05-14 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-03-19 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-26 | Herabstufung | Argus | Buy → Hold |
| 2021-01-20 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-12-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-10-16 | Eingeleitet | Berenberg | Buy |
| 2020-10-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-03-30 | Hochstufung | Jefferies | Hold → Buy |
| 2019-10-23 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2019-09-27 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-09-23 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2019-07-24 | Hochstufung | Atlantic Equities | Underweight → Neutral |
| 2019-06-19 | Bestätigt | BofA/Merrill | Neutral |
| 2019-04-23 | Hochstufung | Argus | Hold → Buy |
| 2019-04-23 | Hochstufung | Macquarie | Neutral → Outperform |
| 2019-02-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2019-01-24 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-01-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-08 | Herabstufung | Goldman | Buy → Neutral |
| 2018-09-20 | Eingeleitet | Atlantic Equities | Underweight |
| 2018-08-16 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-08-15 | Herabstufung | Societe Generale | Buy → Hold |
| 2018-06-21 | Eingeleitet | Morgan Stanley | Underweight |
| 2017-12-14 | Eingeleitet | Deutsche Bank | Hold |
Alle ansehen
Kimberly Clark Corp Aktie (KMB) Neueste Nachrichten
The Kleenex Ultra Soft Facial TissuesKimberly-Clark bets on comfort and subtle skincare - ad-hoc-news.de
Kimberly-Clark Corporation (NASDAQ:KMB) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Kimberly-Clark stock trades steadily as margins and cash flow support valuation - ad-hoc-news.de
Kimberly-Clark Corporation $KMB Shares Sold by Illinois Municipal Retirement Fund - MarketBeat
Sanctuary Advisors LLC Raises Stake in Kimberly-Clark Corporation $KMB - MarketBeat
Kimberly-Clark stock trades steadily as Huggies and tissue demand support earnings and cash flow - ad-hoc-news.de
This is Why Kimberly-Clark Corp (KMB) is a Top Dividend Stock to Invest in According to Jim Simons’ Renaissance Technologies - Yahoo Finance
Bleakley Financial Group LLC Buys 10,808 Shares of Kimberly-Clark Corporation $KMB - MarketBeat
Kimberly-Clark to announce second quarter 2026 financial results - Tissue Online North America
Can Kimberly-Clark's Innovation Strategy Boost Sales Growth? - Yahoo Finance
Kimberly-Clark stock holds steady as consumer tissue demand supports long-term growth - Ad Hoc News
KMB4824926 Bond Profile — Key Metrics - TradingView
KMB Stock Price and Chart — NASDAQ:KMB - TradingView
A Look at Kimberly-Clark Corp (KMB) After 3.0% Decline -- GF Val - GuruFocus
KMB5042722 Bond Profile — Key Metrics - TradingView
The Kleenex Ultra Soft TissuesKimberly-Clark bets on comfort and premium feel - Ad Hoc News
KMB4756839 Bond Profile — Key Metrics - TradingView
Kimberly-Clark Corporation $KMB Shares Purchased by Fifth Third Bancorp - MarketBeat
KMB4008578 Bond Profile — Key Metrics - TradingView
Smart Money Is Buying Kimberly-Clark Corp. (KMB) - The Acquirer's Multiple
KMB.GU Bond Profile — Key Metrics - TradingView
Cottonelle Ultra ComfortCare toilet paper by Kimberly-Clark Corp.everyday premium roll with dense - Ad Hoc News
Sumitomo Mitsui Trust Group Inc. Sells 22,796 Shares of Kimberly-Clark Corporation $KMB - MarketBeat
Church & Dwight vs. Kimberly-Clark: Which Consumer Goods Stock Is a Better Buy in 2026? - The Motley Fool
Church & Dwight vs. Kimberly-Clark: Which Consumer Goods Stock Is a Better Buy in 2026? - The Motley Fool
Kimberly-Clark Corporation - Encyclopedia Britannica
Elevated Capital Advisors LLC Reduces Stock Holdings in Kimberly-Clark Corporation $KMB - MarketBeat
Kleenex Tücher by Kimberly-Clark Corp.everyday tissues in a B2B focus - Ad Hoc News
BofA Securities Maintains Kimberly-Clark(KMB.US) With Buy Rating - Moomoo
Kimberly-Clark investment helps Ohio secure 2026 Silver Shovel Award - Tissue Online North America
Kimberly-Clark stock holds steady as consumer tissue demand supports long-term earnings - Ad Hoc News
Money Concepts Capital Corp Has $6.99 Million Stock Position in Kimberly-Clark Corporation $KMB - MarketBeat
Kimberly-Clark stock stays supported as tissue and diaper demand underpins earnings outlook - Ad-hoc-news.de
Despite Realigning Its Portfolio, Kimberly Is Unwavering in Its Commitment to Brand Investments - Morningstar
Kimberly-Clark stock steadies on consumer staples demand - Ad-hoc-news.de
RBC Capital Maintains Kimberly-Clark(KMB.US) With Buy Rating, Maintains Target Price $162 - Moomoo
KMB Stock Quote Price and Forecast - CNN
Kimberly-Clark Corp (KMB) Shares Fall 3.3% -- What GF Score of 6 - GuruFocus
Kimberly-Clark (KMB) Has a Productivity-and-Cash Engine the Slow-Growth Staples Label Misses - AlphaStreet
Kimberly-Clark Corp refines its tissue strategy. Defensive consumer demand supports the business - Ad Hoc News
Kimberly-Clark (NASDAQ:KMB) Given New $110.00 Price Target at Wells Fargo & Company - MarketBeat
This 4.5%-Yielding Dividend Stock Is Beating the S&P 500 and the Nasdaq. 3 Reasons That Can Continue in the Second Half of 2026 - AOL.com
Stephens Inc. AR Grows Position in Kimberly-Clark Corporation $KMB - MarketBeat
Kimberly-Clark edges forward with hygiene demand. Steady S&P 500 member focuses on cash returns - Ad-hoc-news.de
Kimberly-Clark sets Aug. 4 Q2 results call and analyst Q&A - Stock Titan
Kimberly-Clark Project Helps Ohio Earn National Recognition - Business Journal Daily
Kimberly-Clark Corporation $KMB Stock Holdings Lifted by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
KMBKimberly-Clark Corp Latest SEC Filings - Finviz
Can Kimberly-Clark's Productivity Offset Rising Input Costs? - Yahoo Finance
Arbex begins operations as independent joint venture between Kimberly-Clark and Suzano - Tissue Online North America
KMB News | KIMBERLY-CLARK CORP (NASDAQ:KMB) - ChartMill
Finanzdaten der Kimberly Clark Corp-Aktie (KMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):